09 January 2021>: Clinical Research
Plasma Heat Shock Protein 90 Alpha: A Valuable Predictor of Early Chemotherapy Effectiveness in Advanced Non-Small-Cell Lung Cancer
Bo Zhong 1ACE , Juxin Shen 1AEG* , Chunyi Zhang 1BDE , Guozhong Zhou 2BE , Yuefang Yu 1DE , E Qin 1BE , Jixian Tang 1DE , Dongping Wu 3DE , Xiaochao Liang 1BEDOI: 10.12659/MSM.924778
Med Sci Monit 2021; 27:e924778
Table 1 Patient baseline data.
Characteristic | N=60 |
---|---|
Sex | |
Male | 32 (53.3%) |
Female | 28 (46.7%) |
Age | 66.38±4.25 |
Stage | |
IIIB | 32 (53.3%) |
IV | 28 (46.7%) |
ECOG | |
0 | 18 (30%) |
1 | 42 (70%) |
Pathological type | |
Adenocarcinoma | 24 (40%) |
Squamous cell carcinoma | 36 (60%) |